Stratos Wealth Partners, Ltd. Synthetic Biologics, Inc. Transaction History

Stratos Wealth Partners, Ltd.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Jan 14, 2022	SELL	$2.7 - $4.5 $27,000 - $45,000	-10,000 Closed	0 $0
Q2 2021 Jul 19, 2021	SELL	$4.6 - $7.2 $3,909 - $6,120	-850 Reduced 7.83%	10,000 $6,000
Q1 2021 Apr 27, 2021	BUY	$5.0 - $11.7 $54,250 - $126,944	10,850 New	10,850 $7,000

Ticker SYN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 15,844,100
Market Cap $9.51M
Description
Synthetic Biologics, Inc., a clinical-stage company, develops therapeutics to treat diseases in areas of high unmet need. The company's lead product candidates include SYN-004 designed to degrade various commonly used intravenous beta-lactam antibiotics in gastrointestinal (GI) tract for the prevention of microbiome damage, clostridium difficile...

Get notified when there are updates to the investment portfolio of Stratos Wealth Partners, Ltd., based on Form 13F filings with the SEC.

Stay updated on Stratos Wealth Partners, Ltd. with notifications on news.